Skip to main content

Table 1 Evidence from clinical and neuronal investigations of sleep-wake dyshomeostasis and circadian dysregulations in pathologically confirmed tauopathies

From: Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: evidence from human studies and animal models

Tauopathies (confirmed pathologically) with sleep-wake dyshomeostasis and circadian dysregulations

Evidence of sleep-wake-circadian disturbances in clinical records

Investigation of the neuronal basis of sleep-wake disturbances a)

Reference a)

3R + 4R

Alzheimer’s disease (AD)

Yes

Yes

[9,10,11,12,13,14,15]

Chronic traumatic encephalopathy (CTE)

Yes

Yes

[16,17,18]

Postencephalitic parkinsonism

Yes b)

Not tested

[19]

Primary age-related tauopathy (PART)

Not tested

Not tested

 

4R

Progressive supranuclear palsy (PSP)

Yes

Yes

[20, 21]

Corticobasal degeneration (CBD)

Yes

Yes

[11, 20]

Argyrophilic grain disease (AGD)

No

Not tested

 

Aging-related tau astrogliopathy (ARTAG)

No

Not tested

 

Globular oligodendroglial inclusions (GGT)

Not tested

Not tested

 

3R

Pick’s disease (PiD)

Yes

Not tested

[22, 23]

  1. a) Specifically for involvement of sleep/wake-promoting nuclei or SCN
  2. b) A case study (1 case)